Foam respiratory mask

Information

  • Patent Grant
  • 11129953
  • Patent Number
    11,129,953
  • Date Filed
    Thursday, June 28, 2018
    5 years ago
  • Date Issued
    Tuesday, September 28, 2021
    2 years ago
Abstract
A patient interface for delivering breathable gas to a patient includes a foam interfacing portion adapted to provide a nasal interface to contact under and around the patient's nose in use and including an orifice adapted to surround both the patient's nares in use, and a positioning and stabilizing structure to support the foam interfacing portion in an operative position on the patient's face. The positioning and stabilizing structure is structured to provide a range of rotational, axial, and/or lateral movement to the foam interfacing portion while maintaining a sufficient interface and resisting the application of tube drag and/or headgear tension to the foam interfacing portion.
Description
FIELD OF THE INVENTION

The present invention relates to a respiratory mask used for treatment, e.g., of Sleep Disordered Breathing (SDB) with Continuous Positive Airway Pressure (CPAP) or Non-Invasive Positive Pressure Ventilation (NIPPY). In particular, the present invention relates to a respiratory mask with a foam contacting portion. Also, the present invention relates to a respiratory mask that is comfortable, easy to use and requires little maintenance.


BACKGROUND OF THE INVENTION

Typically, respiratory therapy is delivered in the form of a respiratory mask or mask system positioned between a patient and apparatus providing a supply of pressurized air or breathing gas. Mask systems in the field of the invention differ from mask systems used in other applications such as aviation and safety in particular because of their emphasis on comfort. This high level of comfort is desired because patients must sleep wearing the masks for hours, possibly every night for the rest of their lives. In addition, therapy compliance can be improved if the patient's bed partner is not adversely affected by the patient's therapy and wearing of the mask generally.


Mask systems typically have a highly clinical aesthetic (as will be described below). This may lead to patients becoming embarrassed about their therapy since the clinical aesthetic serves as a blatant reminder that they are ill and consequently can leave a negative perception of the patient in the mind of an observer.


Mask systems typically, although not always, comprise (i) a rigid or semi-rigid portion often referred to as a shell or frame, (ii) a soft, patient contacting portion often referred to as a cushion, and (iii) some form of headgear to hold the frame and cushion in position. If the mask system does include multiple components, at least some assembly and adjustment may be required, which can be difficult for patients who may suffer from lack of dexterity, etc. Further, mask systems often include a mechanism for connecting an air delivery conduit. The air delivery conduit may preferably be connected to a blower or flow generator.


Patient contacting portions, e.g., cushions, are typically constructed of a silicone material, but patient contacting portions including foam are known. For example, U.S. Pat. No. 5,429,683 (Le Mitouard) discloses a lining for a mask made of a polyurethane foam covered with skin (e.g., latex or silicone). However, skinned foam does not allow the portion in contact with the face to breathe, which can lead to skin irritation, and the sealing portion may be subject to creasing which may cause discomfort and lead to leak. The skin can also feel too hard for some patients, depending on the thickness and support structure. The skin also does not allow a high degree of local deformation and may be subject to tension transfer across its surface, which can result in shifting of the mask on the face and loss of seal/comfort.


A range of mask systems are known including nasal masks, nose & mouth masks, full face masks and nasal prongs, pillows, nozzles & cannulae. Masks typically cover more of the face than nasal prongs, pillows, nozzles and cannulae.


There is a continuous need in the art to provide mask systems with a high level of comfort and usability and a newly perceived need to provide mask systems having improved aesthetics.


SUMMARY OF THE INVENTION

One aspect of the invention is to provide an attachable interfacing portion for a respiratory mask.


Another aspect of the invention is to provide a removably attachable interfacing portion for a respiratory mask.


In an embodiment, the respiratory mask is a nasal mask, and the interfacing portion is a foam contacting portion that is arranged in use between the nose of the patient and the mask system. The foam contacting portion provides a seal between the nares of the patient and the mask system so as to deliver pressurized gas to the patient. The mask system may include a cushion, gusset and/or frame.


In one form, the nasal mask system may be provided with a releasable and replaceable foam contacting portion that it connected to the mask system by at least one connector.


In embodiments, the foam contacting portion may be connected to the mask system (e.g., connected to the frame, decoupling element, and/or headgear) by male and female connectors, a hook and loop arrangement, a press stud arrangement, hook and loop material, a clip arrangement, and/or an adhesive. In another embodiment, the foam contacting portion may be connected or otherwise provided to the mask system using existing structure on the frame, decoupling element, and/or headgear, e.g., without connectors and/or adhesive.


In another form, the nasal mask system may be provided with a removable foam contacting potion that adjoins to the mask system by wrapping about or around the mask system.


In one form, the foam contacting portion may be retrofitted to an existing nasal mask.


In another form, the foam contacting portion includes a foam sleeve that that may be slidingly positioned over a support structure. The foam sleeve may be removably positionable. In one form, the foam sleeve is sock-like.


Another aspect of the invention relates to a patient interface for delivering breathable gas to a patient including a foam interfacing portion adapted to provide a nasal interface to contact under and around the patient's nose in use and including an orifice adapted to surround both the patient's nares in use, and a positioning and stabilizing structure to support the foam interfacing portion in an operative position on the patient's face. The positioning and stabilizing structure is structured to provide a range of rotational, axial, and/or lateral movement to the foam interfacing portion while maintaining a sufficient interface and resisting the application of tube drag and/or headgear tension to the foam interfacing portion.


Other aspects, features, and advantages of this invention will become apparent from the following detailed description when taken in conjunction with the accompanying drawings, which are a part of this disclosure and which illustrate, by way of example, principles of this invention.





BRIEF DESCRIPTION OF THE DRAWINGS

The accompanying drawings facilitate an understanding of the various embodiments of this invention. In such drawings:



FIG. 1 depicts a side view of a nasal mask with a foam contacting portion in use according to an embodiment of the present invention;



FIG. 2 depicts a top view of the nasal mask of FIG. 1;



FIG. 3 depicts a front view of the nasal mask of FIG. 1;



FIGS. 4 and 5 depict isometric views of a nasal mask with a foam contacting portion assembled according to an embodiment of the present invention;



FIG. 6 depicts a side view of the nasal mask of FIGS. 4 and 5;



FIG. 7 depicts a front view of the nasal mask of FIGS. 4 and 5;



FIG. 8 depicts a top view of the nasal mask of FIGS. 4 and 5;



FIG. 9 depicts a rear view of the nasal mask of FIGS. 4 and 5;



FIG. 10 depicts a side view of a foam contacting portion according to an embodiment of the present invention;



FIG. 11 depicts a side view of an unassembled foam contacting portion and mask system according to an embodiment of the present invention;



FIG. 12 depicts a side view of an assembled foam contacting portion and mask system according to an embodiment of the present invention;



FIG. 13 depicts front and rear views of an assembled foam contacting portion and mask system in use according to an embodiment of the present invention;



FIG. 14 depicts a top view of a foam contacting portion with an intermediate connecting structure according to an embodiment of the present invention;



FIGS. 15A, 15B, 15C, and 15D depict top views of foam contacting portions according to embodiments of the present invention;



FIG. 16 depicts an isometric view of a foam contacting portion according to an embodiment of the present invention;



FIG. 17 depicts a rear view of the foam contacting portion of FIG. 16;



FIG. 18 depicts a top view of the foam contacting portion of FIG. 16;



FIGS. 19, 20 and 21 depict various views of a foam contacting portion reconnecting to itself about a mask system according to an embodiment of the present invention;



FIG. 22 depicts a side view of an unassembled foam contacting portion and mask system with a hook and loop connection according to an embodiment of the present invention;



FIGS. 23 and 24 depict a side view of a hook and loop connection in assembly according to an embodiment of the present invention;



FIG. 25 depicts a rear view of a hook and loop connection in assembly according to an embodiment of the present invention;



FIGS. 26, 27 and 28 depict various views of an assembled foam contacting portion and mask system with a hook and loop connection using headgear connectors according to an embodiment of the present invention;



FIGS. 29 and 30 depict a side view of an unassembled foam contacting portion and mask system with a hook and loop connection using a detent according to an embodiment of the present invention;



FIG. 31 depicts a side view of an unassembled foam contacting portion and mask system with a stud connection according to an embodiment of the present invention;



FIG. 32 depicts a front view of an assembled foam contacting portion and mask system with a clipped connection according to an embodiment of the present invention;



FIG. 33 depicts a back view of an assembled foam contacting portion and mask system with a clipped connection according to an embodiment of the present invention;



FIG. 34 depicts a side view of an assembled foam contacting portion and mask system with a clipped connection according to an embodiment of the present invention;



FIG. 35 depicts a top view of an assembled foam contacting portion and mask system with a clipped connection according to an embodiment of the present invention;



FIG. 36 depicts a rear view of an assembled foam contacting portion and mask system with a clipped connection according to an embodiment of the present invention;



FIG. 37 depicts a front view of a foam contacting portion with a clip connection according to an embodiment of the present invention;



FIG. 38 depicts a back view of a foam contacting portion with a clip connection according to an embodiment of the present invention;



FIG. 39 depicts a side view of a foam contacting portion with a clip connection according to an embodiment of the present invention;



FIG. 40 depicts a top view of a foam contacting portion with a clip connection according to an embodiment of the present invention;



FIG. 41 depicts a rear view of a foam contacting portion with a clip connection according to an embodiment of the present invention;



FIGS. 42 and 43 depict the naris region of a patient;



FIG. 44 depicts a top view of a foam contacting portion according to an embodiment of the present invention;



FIG. 45 depicts a side view of the foam contacting portion of FIG. 44;



FIG. 46 depicts a side view of a locking pin according to an embodiment of the present invention;



FIG. 47 depicts a side view of a mask system according to an embodiment of the present invention;



FIG. 48 depicts a side view of a mask system according to an embodiment of the present invention;



FIG. 49 depicts an isometric view of a support structure according to an embodiment of the present invention;



FIG. 50 depicts a bottom view of the support structure of FIG. 49;



FIG. 51 depicts a top view of the support structure of FIG. 49;



FIG. 52 depicts a front view of the support structure of FIG. 49;



FIG. 53 depicts a rear view of the support structure of FIG. 49;



FIG. 54 depicts a side view of the support structure of FIG. 49;



FIG. 55 depicts an isometric view of a mask system according to an embodiment of the present invention;



FIG. 56 depicts a top view of the mask system of FIG. 55;



FIG. 57 depicts a side view of the mask system of FIG. 55;



FIG. 58 depicts a bottom view of the mask system of FIG. 55; and



FIG. 59 depicts a front view of the mask system of FIG. 55.





DETAILED DESCRIPTION OF ILLUSTRATED EMBODIMENTS

The following description is provided in relation to several embodiments which may share common characteristics and features. It is to be understood that one or more features of any one embodiment may be combinable with one or more features of the other embodiments. In addition, any single feature or combination of features in any of the embodiments may constitute additional embodiments.


In this specification, the word “comprising” is to be understood in its “open” sense, that is, in the sense of “including”, and thus not limited to its “closed” sense, that is the sense of “consisting only of”. A corresponding meaning is to be attributed to the corresponding words “comprise”, “comprised” and “comprises” where they appear.


The term “air” will be taken to include breathable gases, for example air with supplemental oxygen. It is also acknowledged that the positive airway pressure (PAP) devices or flow generators described herein may be designed to pump fluids other than air.


In broad terms, a patient interface in accordance with an embodiment of the invention may comprise three functional aspects: (i) interfacing, (ii) positioning and stabilizing, and (iii) air delivery. These three functional aspects may be constructed from one or more structural components, with a given structural component potentially fulfilling more than one function. For example, a mask frame may serve as part of a positioning and stabilizing function and allow the supply of air.


In an embodiment, as shown in FIGS. 1-3, the patient interface 10 may include a mask system 100, a positioning and stabilizing structure 30, and an air delivery system 130. Mask system 100 may include an interfacing portion 200. Positioning and stabilizing structure 30 may include a frame 110 and/or decoupling element 170 and/or a headgear 50 (that may include top straps 60, a back strap 70, one or more side straps 80 and rigidizers 90). Air delivery system 130 may include: an elbow 140 and a tube 150.


In addition, a patient interface 10 in accordance with an embodiment of the invention may perform other functions including venting of exhaled gases, decoupling of potentially seal disruptive forces and adjustment for different sized faces. Venting may be performed by different structures, e.g., such as the frame 110, the elbow 140 and/or the tube 150.


1. Interfacing


1.1 Introduction


In an embodiment, the interfacing function is provided by a nasal cushion (or “nasal cradle”) that is placed at an entrance to the patient's nares. The nasal cushion is structured to form an interface with the nares and is shaped, oriented, sized and constructed so as provide a fit with a range of differently shaped and located flares.


The nasal cushion may be formed of foam (also referred to as a foam contacting portion). As shown generally in FIGS. 1-3, nasal cushion or foam contacting portion 200 may be positioned at the nares or under the nose. Foam contacting portion 200 may cushion the nares of the patient to increase comfort. Foam contacting portion 200 may also seal with the nares of the patient, e.g., if the foam is a closed cell foam. Alternatively, foam contacting portion 200 may be constructed from an open cell foam or a foam with some open cells, such that it allows a certain degree of leak while delivering sufficient pressure to the patient in the intended therapeutic effect. Instead, such a foam will allow some air to pass through the foam and leak gases into the atmosphere. This may be desirable to assist in venting.


In an embodiment, the foam contacting portion 200 may be maintained in position using stabilizing portions or rigidizers 90 attached to, or formed as part of headgear 50. In this form, the mask system 100 may be generally arranged per ResMed's MIRAGE SWIFT™ nasal pillows and as described in PCT Publication No. WO 2004/073778 (Gunaratnam et al), the contents of which are hereby expressly incorporated by cross-reference.


1.2 Foam


The foam used for the foam contacting portion 200 may be the same as that disclosed in PCT Publication No. WO 2008/070929 (Veliss et al), filed Dec. 14, 2007, which is incorporated herein by reference in its entirety. Alternatively, any suitable foam may be used, for example skinned foam.


In another embodiment, the cushion or foam contacting portion 200 of the mask system 100 may be the cushion disclosed in U.S. patent application Ser. No. 12/219,852 (Guney et al), filed Jan. 11, 2008, which is incorporated herein by reference in its entirety.


The foam contacting portion 200 may be a single piece of foam. In another form, the foam contacting portion 200 may be multiple pieces of foam joined together by any suitable means, for example gluing or insert molding.


As shown in the embodiment of FIGS. 4-9, the foam contacting portion 200 may have an orifice 250 for delivery of pressurized air. In one form, the orifice 250 provided to the foam contacting portion 200 will align with an orifice or aperture 175 or orifices in the decoupling element 170 (e.g., see FIGS. 11 and 12) and/or aperture 115 on frame 110 (e.g., see FIGS. 8 and 9) which is connected to elbow 140 and tube 150, so as to deliver pressurized gas to the patient. The orifice 250 or orifices provided to the foam contacting portion 200 may be the same size, smaller or larger than the aperture 175 and/or aperture 115.


In an embodiment, the thickness of foam contacting portion 200 may be 0.5-50 mm. For example, the thickness of foam contacting portion 200 may be 7-15 mm. In an exemplary embodiment, the thickness of foam contacting portion 200 may be 11 mm.


In an embodiment, the length of foam contacting portion 200 may be 10 mm-200 mm (or its largest length if it is not square). For example, the length of foam contacting portion 200 may be 40-120 min. In an exemplary embodiment, the length of foam contacting portion 200 may be 105 mm. In an embodiment, the width of foam contacting portion 200 may be 10 mm-100 mm (or its largest width if it is not square). For example, the width of foam contacting portion 200 may be 30-70 mm. In an exemplary embodiment, the width of foam contacting portion 200 may be 50 mm.


As disclosed in PCT Publication No. WO 2008/070929 (Veliss et al), the foam contacting portion may be impermeable or air permeable. Air permeability may give the foam interface a unique breathability, which acts to increase the comfort at the interface with the user's nose and skin. All air permeability aspects of PCT Publication No. WO 2008/070929 (Veliss et al) are incorporated herein by reference, and all embodiments in this disclosure may contain foam that is air permeable.


In another embodiment, the foam contacting portion 200 may be retrofitted to existing mask designs, for example ResMed's MIRAGE SWIFT™ as disclosed in U.S. Pat. No. 7,318,437 (Gunaratnam et al) and U.S. Patent Publication No. 2005/0241644 (Lynch et al), each of which is incorporated herein by reference.


1.3 Interface Attachment


Desirable features of an attachment mechanism of the foam contacting portion 200 to the positioning and stabilizing structure may include: satisfactory comfort, effective position of the interfacing portion and/or being easy to use. Due to the softness of foam, hard connecting pieces may in some forms be felt by the patient's face through the foam. Thus, attachment mechanisms that avoid such patient contact may be desired.


In another embodiment, the foam contacting portion 200 may be connected to a positioning and stabilizing structure such as a frame 110 and/or a decoupling element 170 or any other part of the mask system 100 by connecting elements such as hook and loop connectors, press studs, etc. Exemplary connecting elements are described below.


1.3.1 Wrap


In an embodiment, as shown in FIG. 4-13, the foam contacting portion 200 may be connected to a mask system 100 by wrapping the foam over or around the mask system 100. The foam contacting portion 200 may be secured in its wrapped position on the mask system 100 by a male connector 300 and female connector 310 or series of connectors 300, for example see FIGS. 9, 10-11, 13, 16 and 17. In the illustrated embodiment, the male connector 300 is provided to the foam contacting portion 200 and the female connector 310 is provided to the frame 110 and/or decoupling element 170. However, it should be appreciated that the reverse arrangement is possible, i.e., male connector may be provided to the frame and/or decoupling element and the female connector may be provided to the foam contacting portion.


The foam contacting portion 200 may be any shape such as generally rectangular (see FIG. 15A), oval (see FIGS. 15C and 16-18) or hexagonal (see FIG. 15B). Additionally, the foam contacting portion 200 may be any irregular shape, e.g., Y-shaped (see FIG. 15D).


As shown in FIG. 11, the foam contacting portion 200 may have male connectors 300 that engage with opposing female connectors 310 on the mask system 100. The female connectors 310 on the mask system 100 may be on a flexible component (for example, decoupling element 170). Alternatively, the female connectors 310 on the mask system 100 may be on a less flexible component (for example, frame 110).


The male connectors 300 may be fixed to the foam contacting portion 200 by a range of techniques, for example glue. The female connectors 310 may be fixed to the mask system 100 by a range of techniques, for example glue. In another form, the female connectors 310 may be co-molded to the mask system 100. However, the male and female connectors may be permanently or removably attached in other suitable manners.


In a further embodiment, the foam contacting portion 200 may not connect to the mask system 100 by male connectors 300 on the foam contacting portion 200 and female connectors 310 on the mask system 100, e.g., instead the foam contacting portion 200 may reconnect to itself. For example, as shown in FIG. 19-21, the male connectors 300 will be placed at one end of the foam contacting portion 200 with the female connectors 310 at the other end of the foam contacting portion 200, which can then be wrapped around the mask system 100 and connected together at connection points 320.


In another embodiment, the foam contacting portion may include a stretchable foam structured to expand or stretch to fit over the frame, decoupling element, etc., and then return to its original shape to tightly grasp the intended surface.


In a further embodiment, the connection mechanism may be via a hook 330 and loop 340 system, as shown in FIGS. 22-25. The male connectors 300 on the foam contacting portion 200 may take the form of hook 330. The female connectors 310 on the mask system 100 may take the form of loop 340. The loop 340 may be an additional piece attached to the mask system 100 or it may be a hole or aperture in the mask system 100 to allow engagement of the hook 330 (e.g., see FIGS. 23-25).


Alternatively, the reverse arrangement is possible (i.e., loop 340 or hole on the foam contacting portion 200 and hook 330 on the mask system 100). In this form, the loop 340 may be a hole in the foam contacting portion 200, and the hook 330 on the mask system 100 may be an attached or co-molded hook 330 or may be a pre-existing structure on the mask system 100. For example, FIGS. 26-28 illustrate an embodiment in which connectors 350 on the frame 110 (e.g., headgear connecting portions for attaching headgear) extend through respective openings 340 provided to ends of the foam contacting portion. In yet another form, the hook 330 may have a detent 335 to ensure retention of the loop 340, as shown in FIGS. 29-30. The hook 330 and loop 340 may be made from a range of different materials or combination of materials, including but not limited to: wire, silicone, polycarbonate, polypropylene, TPE, polyethylene or any other suitable material.


In a further embodiment, the connection mechanism may be achieved by a press stud 360 as shown in FIG. 31. The male connectors 300 on the foam contacting portion 200 may take the form of a stud 360. The female connectors 310 on the mask system 100 (e.g., frame 110 or decoupling element 170) may take the form of a hole or recess 370. Alternatively, the reverse arrangement is possible (i.e., hole 370 on the foam contacting portion 200 and stud 360 on the mask system 100). The press stud 360 may be made from materials such as metals, polymers or any other suitable material.


In a further embodiment, as shown in FIGS. 44-47, the foam contacting portion 200 may be provided with apertures 380 that are intended to be positioned adjacent alignment holes 180 on the mask system 100. A pin or anchor 390 may be used to secure foam contacting portion 200 onto mask system 100 by inserting the anchor 390 through apertures 380 and alignment holes 180 (see FIG. 47). Anchor 390 may have one or more locking portions 395 so that once in position, the foam contacting portion 200 remains in its position on the mask system 100.


In a further embodiment, the foam contacting portion 200 may be wrapped onto or around the mask system 100 and connected by other type of mechanisms, including but not limited to hook and loop material (e.g., Velcro') or magnets.


In a further embodiment, the wrapped foam contacting portion 200 may be permanently connected to the mask system 100, for example, by gluing, welding or co-molding. For example, the mask system 100 may be made from a foam that can be co-molded with another foam to form the foam contacting portion 200. In yet another embodiment, the foam may be a flocking foam that is provided to (e.g., sprayed onto) the frame, decoupling element, etc.


Exemplary benefits of the wrapped foam contacting portion 200 may include: the ease of sealing the foam contacting portion with the patient and the mask system, continuity of feel, top lip comfort, retro-fitability, intuitiveness of assembly and mass production capability. Other benefits of the wrapped foam may include: if the intention is to replace the foam contacting portion on a regular basis (e.g., daily, weekly or monthly—as disclosed in PCT Publication WO 2008/070929 (Veliss et al)), the portion that is disposed of is small compared to the mask system. This embodiment therefore minimizes waste and maximizes efficiencies around the packaging, storage and transportation of the replacement foam contacting portions.


1.3.2 Clip


In another form, the foam contacting portion 200 may be connected to a mask system 100 by clipping the foam into the mask system 100. The foam contacting portion 200 may be secured in its clipped position on the mask system 100, e.g., by an interference fit.



FIGS. 32-36 show foam contacting portion 200 clipped into the mask system 100 by a clip 400. Clip 400 is slidably engaged with mask system 100 and secures by an interference fit with a portion (e.g., frame 110) of the mask system 100. In an embodiment, clip 400 may be interference fit via locking bumps 410 with step 120 on mask system 100 (see FIG. 48). In an alternative embodiment, clip 400 may be secured in place by another other means, including but not limited to: screw type mechanism. In another alternative embodiment, the clip 400 may be permanently secured to mask system 100, for example, by adhesive. In another alternative embodiment, clip 400 may be co-molded or be continuous with the mask system 100.


The clip 400 may be fixed to the foam contacting portion 200 permanently, for example by adhesive or co-molding. Alternatively, clip 400 may be releasably connected to foam contacting portion 200, including but not limited to: hook and loop material (e.g., Velcro™.


In an embodiment, clip 400 may have a support structure 420 that may have a generally elliptical cross section (e.g., see FIGS. 33, 34, 37-39, and 41). Support structure 420 may engage with mask system 100 to secure the foam contacting portion 200 in place. Support structure 420 may also assist in presenting the foam contacting structure 200 at a desirable orientation to the patient's nose. Support structure 420 may be hollow to allow the flow of pressurized gas from air delivery tube 150 to orifice 250 of foam contacting portion 200.


In an embodiment, clip 400 may comprise an upper surface 440 that engages with foam contacting portion 200 (e.g., see FIGS. 33, 34, 39, and 41). Upper surface 440 may be generally planar. In an exemplary embodiment, upper surface 440 may be curved to conform to the contours of the patient's face to improve comfort and seal of the mask. Upper surface 440 may be as wide as the foam contacting portion 200. Alternatively, upper surface 440 may be smaller or less wide than the foam contacting portion 200 such that the outer edge of foam contacting portion 200 is able to overhang the upper surface 440 and thus flex at its edge. This arrangement may allow the foam contacting portion to better conform to the patient's face.


1.3.3 Other


In a further embodiment, the foam contacting portion 200 need not be connected to the mask system 100 via connecting elements. Rather, the foam contacting portion 200 may be placed on the mask system 100 by other means such as pulled over (e.g., like a sock). For example, as shown in FIGS. 55-59, contacting portion 200 may be a cylindrical or continuous portion of foam with an opening 800 to receive the frame 110 and headgear connecting portions 112. Foam contacting portion 200 may also have orifice 250 for interfacing with aperture 175 in decoupling portion 170 to allow the delivery of breathable gas to the patient. Foam contacting portion 200 may also have opening 260 for interfacing with aperture 115 of frame 110.


In another embodiment, the foam contacting portion 200 may be connected to an intermediate connecting structure 315 (see FIG. 14). This intermediate connecting structure 315 may connect to the foam contacting portion 200 on one side and connect to the mask system 100 on the other side. This may include but is not limited to: the foam contacting portion 200 may be connected to a piece of flexible fabric material (e.g., Breath-O-Prene™ by Accumed) which is then connected to the mask system 100 (or part(s) of the mask system 100). Alternatively, the intermediate connecting structure 315 shown in FIG. 14 may not connect to the mask system 100, instead it may wrap around the mask system and the left and right intermediate connecting structures 315 may connect to each other.


In a further embodiment, the foam may be fixed (e.g., using an adhesive) to an adaptor or clipping mechanism, which in turn connects via an interference fit onto the mask frame.


1.4 Interface Size


In a further embodiment, the foam may be provided in various sizes to accommodate varying anthropometric requirements. Typical nasal pillow designs have sizes based on the nostrils of the population as these pillows seal around the nares. However, the same sizing may not be ideal for the foam contacting portion 200 as it does not seal on the edge of, or inside the nares. Instead sizing may be based on sealing against the area around the nares (as indicated by the dashed line d1 around the nares in FIG. 42).



FIG. 42 presents a two-dimensional view of the underside of the nose and defines the areas that may be considered for sealing the nostrils. The orifice 250 on the foam contacting portion 200 should be within the bounds of the area of the nose (shown by the dashed line d2 in FIG. 42) so that the mask can sealingly engage with the nose. Should the orifice 250 be any larger than the region of the nose (dashed line d2), the mask may leak. In an embodiment, the orifice 250 should not be any smaller than the region within the nares (shown by the dashed line d1) so as to occlude the patient's airway. The orifice in the foam may encroach on the nostril openings on some noses and some degree of partial occlusion may be acceptable.


In a further embodiment, there may be one orifice 250 in the foam contacting portion 200. In one form, the orifice 250 in the foam contacting portion 200 may be generally trapezoidal or ‘D’ shaped as shown in FIGS. 8, and 16-18. In another form, the orifice 250 may be circular or oval (as shown in FIGS. 14 and 15A-15D), square (not shown) or any other shape fitting within the aforementioned limits.


In a further embodiment and referring to FIG. 43, the orifice 250 in the foam contacting portion 200 may be 15-50 mm wide (indicated in FIG. 43 by dimension 500). In an exemplary embodiment, the orifice 250 in the foam contacting portion 200 may be about 22 mm wide. In another exemplary embodiment, the orifice 250 in the foam contacting portion 200 may be about 31 mm wide. In an embodiment, the orifice 250 in the foam contacting portion 200 may be 5-30 mm high (indicated in FIG. 43 by dimension 600). In an exemplary embodiment, the orifice 250 in the foam contacting portion 200 may be about 11 mm high. In another exemplary embodiment, the orifice 250 in the foam contacting portion 200 may be about 16 mm high.


In a further embodiment, the orifice 250 in the foam contacting portion 200 may have an angle of 10-80° (indicated in FIG. 43 by dimension 700). In an exemplary embodiment, angle 700 is about 67°. In another exemplary embodiment, angle 700 is about 50°.


In a further embodiment, there may be more than one orifice 250 in the foam contacting portion 200. In one form, there may be two orifices 250, e.g., each generally oval in shape. In another form, there may be a plurality of orifices 250 (for example, 3, 4, 5, 10 or more), e.g., each that are generally round. In another form, there may be multiple orifices 250 of any shape, within the limits shown above (indicated by the dashed lines d1 and d2 in FIG. 42).


2. Positioning and Stabilizing Structure


2.1 Introduction


A patient interface 10 provides a structure for suitable positioning, suspension and stabilizing of the interfacing portion 200 of the patient interface 10 at an entrance to the airways of the patient. This structure includes: the decoupling element 170, the frame 110 and headgear 50 with rigidizers 90. The decoupling element 170 acts as a form of suspension system or force insulation system whereby it isolates forces from one portion of the patient interface 10 from another portion of the patient interface 10. The headgear 50 and rigidizers 90 form a structure that may resist bending in one or more directions (and/or from tube drag) and yet is flexible to conform to different facial geometries, or to move in response to other potentially disruptive forces. In combination with the suspension system, a greater range of movement of a mask system in accordance with an embodiment of the invention can be accommodated without disrupting the seal than in prior art mask systems.


2.2 Frame


A frame 110 in accordance with an embodiment of the present invention as shown in FIGS. 49-54, serves a number of functions, including: a connection point to decoupling element 170, headgear rigidizers 90 and elbow 140. A given functional feature may reside in different structures. For example, the stabilizing portion of headgear 50 may be formed as part of a frame 110 either additionally or alternatively.


Frame 110 may connect to the elbow 140 via aperture 115, whereby the elbow clips into the aperture 115, or interfaces with the aperture 115 by any such means so as to join the elbow 140 to the frame 110. Frame 110 may be generally rectangular or any other desired shape, for example see FIGS. 49-54. Frame 110 is intended to support the decoupling element 170 and foam contacting portion 200 and connect the mask system 100 to the headgear 50, thereby securing the mask system 100 on the patient's face. Frame 110 connects to the headgear 50 by connecting portions 112, where rigidizers 90 removably connect to connecting portions 112 (e.g., see FIG. 7). Such a connection is described in U.S. patent application Ser. No. 12/219,852 (Guney), which is incorporated herein by reference in its entirety. Frame 110 may be at least partially constructed from a resilient material such as silicone, polycarbonate, polypropylene, nylon, or any other desired material.


2.3 Decoupling Element


Decoupling element 170 may be generally oval as shown in FIGS. 11 and 49-54 with orifice 175 adapted to align with opening in foam contacting portion 200. Decoupling element 170 may absorb some of the forces from the frame, headgear and tube by flexing and compressing (e.g., like a gusset or suspension system) so as to prevent misalignment of the foam contacting portion 200 with the nares of the patient. Decoupling element 170 may be formed from a flexible material such as silicone. Decoupling element 170 may be connected to frame 110 by an interference fit. Alternatively, decoupling element 170 may be permanently fixed or formed with the frame 110 by co-molding or glue. Decoupling element 170 may also be attached to the foam contacting portion. In one form, the foam contacting portion 200 is a layer of foam that is wrapped, connected, slid or otherwise positioned on a supporting structure.


In a further embodiment, the decoupling element 170 of the support structure may be the decoupling element disclosed in U.S. patent application Ser. No. 12/219,852 (Guney), which is incorporated herein by reference in its entirety. In an embodiment, the frame 110 of the mask system 100 may be the frame disclosed in U.S. patent application Ser. No. 12/219,852 (Guney).


The particularly soft mechanical properties of an exemplary foam (as disclosed in PCT Publication No. WO 2008/070929 (Veliss et al)) means that the foam contacting portion may be provided with support and reinforcement to perform its function with the nasal air passages. The frame 110 and decoupling element 170 may be suitable structures to provide this supporting mechanism, providing appropriate balance between shape and support for positioning the foam contacting portion 200, structural compliance and resilience for comfort on the nose (e.g., allow rotational, axial, and/or lateral movement to resist tube drag and headgear tension).


2.4 Headgear


Headgear 50 may include three main strap sections: top straps 60, back strap 70 and side straps 80. Top straps 60 may be placed over the top of the patient's head and may be one continuous piece of material or multiple pieces of material joined together by a buckle 95 as shown in FIGS. 1-3.


Back strap 70 may be placed around the back of the patient's head and may be one piece of continuous material or multiple pieces of material joined together by a buckle.


Top strap 60 and back strap 70 may be adjusted using hook and loop fasteners (such as Velcro™) or with the buckle 95. Buckle 95 may also have a lock that prevents the top strap 60 from loosening off. Such a buckle 95 with lock is described in U.S. Pat. No. 7,318,437 (Gunaratnam et al), which is incorporate herein by reference in its entirety.


Side straps 80 are generally positioned on the sides of the patient's face, from above or near the ear, passing under the eyes and ending at the nose of the patient. Side straps 80 may be reinforced with rigidizers 90 that may assist in supporting the mask system 100 in position. Rigidizers 90 may be attached to side straps at: the patient contacting side of side straps 80 (not shown), within side straps 80 by co-molding or other such technique (not shown), or on the exterior non-patient contacting side of side straps 80 (see FIGS. 1 and 3). Rigidizers 90 may be connected to side straps 80 by: gluing, stitching, co-molding, or any other suitable means.


Side straps 80 may also include cheek supports 85 that lie generally horizontally on the cheeks of the patient, generally at the cheek bone region, to better position the mask system 100 on the face of the user. Such an arrangement is shown in U.S. patent application Ser. No. 12/219,852 (Guney).


3. Air Delivery


3.1 Introduction


The mask system 100 may be connected to a supply of pressurized breathable gas to deliver therapy to the patient. The air delivery system 130 may include: an elbow 140 and a tube 150 as shown in FIGS. 1-3.


3.2 Elbow


Elbow 140 is generally an L-shaped, hollow cylinder and may be constructed of a generally rigid material such as polycarbonate or polypropylene. Elbow 140 may also include one or more vent holes 160 (see FIG. 3) to allow exhaust gases from the patient to expel into the atmosphere. Elbow 140 may also include a one way anti-asphyxia valve.


In a further embodiment, the elbow 140 may be the same as that disclosed in U.S. patent application Ser. No. 12/219,852 (Guney).


3.3 Tube


Tube 150 is generally a hollow, cylinder with a reinforcing member 155 (see FIGS. 1 and 3) integrally molded into tube 150. The reinforcing member 155 may include a generally helical shape so as to allow the tube 150 to flex without occluding. Tube 150 may be flexible, resilient and stretchable in a longitudinal direction.


Tube 150 may be constructed of a polymer or fabric, e.g., Hytrel™. Such a tube is disclosed in U.S. Provisional Patent Application No. 61/031,407 (Henry et al), filed Feb. 26, 2008, which is incorporated herein by reference in its entirety.


Tube 150 may connect to the elbow 140 so as to deliver breathable gas to the patient through the patient interface 10. The tube 150 may connect to elbow 140 by any reasonable means, such as a clip, interference fit, etc.


In a further embodiment, the tube 150 may be the same as that disclosed in U.S. patent application Ser. No. 12/219,852 (Guney).


In the illustrated forms of the invention, the mask system 100 of which the foam interfacing portion forms a part is generally configured under the nose of the patient. However, in other forms, the mask system 100 may be a nasal or full-face mask, or an oro-nasal mask. For example, in one form, a foam-based under-the-nose configuration may be combined with a gel, silicone or rubber portion, for example a silicone mouth cushion.


While the invention has been described in connection with what are presently considered to be the most practical and preferred embodiments, it is to be understood that the invention is not to be limited to the disclosed embodiments, but on the contrary, is intended to cover various modifications and equivalent arrangements included within the spirit and scope of the invention. Also, the various embodiments described above may be implemented in conjunction with other embodiments, e.g., aspects of one embodiment may be combined with aspects of another embodiment to realize yet other embodiments. Further, each independent feature or component of any given assembly may constitute an additional embodiment. Furthermore, each individual component of any given assembly, one or more portions of an individual component of any given assembly, and various combinations of components from one or more embodiments may include one or more ornamental design features. In addition, while the invention has particular application to patients who suffer from OSA, it is to be appreciated that patients who suffer from other illnesses (e.g., congestive heart failure, diabetes, morbid obesity, stroke, bariatric surgery, etc.) can derive benefit from the above teachings. Moreover, the above teachings have applicability with patients and non-patients alike in non-medical applications.

Claims
  • 1. A patient interface for delivering breathable gas to a patient, the patient interface comprising: a foam interfacing portion formed of foam and adapted to provide a nasal interface, the foam interfacing portion including an orifice adapted to be in fluid communication with both the patient's nares in use; anda positioning and stabilizing structure to support the foam interfacing portion in an operative position on the patient's face,wherein the foam interfacing portion is removably connected to the positioning and stabilizing structure, the foam interfacing portion being wrapped around at least a portion of the positioning and stabilizing structure such that an exterior surface of a bottom underside portion of the foam interfacing portion forms a concave shape extending from a first side of the at least a portion of the positioning and stabilizing structure to a second side of the at least a portion of the positioning and stabilizing structure opposite the first side, the exterior surface of the bottom underside portion of the foam interfacing portion being in direct contact with the positioning and stabilizing structure, andwherein the foam interfacing portion being secured in its wrapped position by one or more connectors.
  • 2. A patient interface according to claim 1, wherein the positioning and stabilizing structure includes a frame, a decoupling element, and/or headgear.
  • 3. A patient interface according to claim 2, wherein the positioning and stabilizing structure includes the decoupling element, and wherein the foam interfacing portion is provided to an exterior surface of the decoupling element.
  • 4. A patient interface according to claim 2, wherein the positioning and stabilizing structure includes the frame and the decoupling element, and wherein the foam interfacing portion is wrapped around the frame and the decoupling element.
  • 5. A patient interface according to claim 2, wherein the positioning and stabilizing structure includes the decoupling element, and wherein the decoupling element is formed from silicone.
  • 6. A patient interface according to claim 2, wherein the foam interfacing portion is secured in position using existing structure on the decoupling element, frame, and/or headgear.
  • 7. A patient interface according to claim 2, wherein the orifice is structured to align with an orifice provided to the frame and/or decoupling element.
  • 8. A patient interface according to claim 2, wherein the positioning and stabilizing structure includes the frame, and wherein the foam interfacing portion covers substantially an entirety of the frame.
  • 9. A patient interface according to claim 1, wherein the connectors include a male connector and a female connector.
  • 10. A patient interface according to claim 9, wherein the foam interfacing portion includes the male connector and a frame and/or decoupling element includes the female connector.
  • 11. A patient interface according to claim 1, wherein the exterior surface of the bottom underside portion of the foam interfacing portion has a first end at a first side of the foam interfacing portion and a second end at an opposite second side of the foam interfacing portion, and wherein the entire exterior surface from the first end to the second end is formed into the concave shape.
  • 12. A patient interface according to claim 11, wherein an exterior surface on a topside patient-contacting portion of the foam interfacing portion has a convex shape that matches a curvature of the concave shape of the exterior surface of the bottom underside portion of the foam interfacing portion.
  • 13. A patient interface according to claim 12, wherein the convex shape of the exterior surface of the topside patient-contacting portion of the foam interfacing portion is configured and positioned to directly contact under the patient's nose in use.
  • 14. A patient interface according to claim 12, wherein a distance between the exterior surface of the bottom underside portion of the foam interfacing portion and the exterior surface of the topside patient-contacting portion of the foam interfacing portion is uniform from the first side of the foam interfacing portion to the second side of the foam interfacing portion.
  • 15. A patient interface according to claim 1, wherein the connectors include a hook and loop arrangement.
  • 16. A patient interface according to claim 1, wherein the connectors include a press stud arrangement.
  • 17. A patient interface according to claim 1, wherein the connectors include a hook and loop material.
  • 18. A patient interface according to claim 1, wherein the connectors include a clip arrangement.
  • 19. A patient interface according to claim 1, wherein the orifice of the foam interfacing portion is D-shaped.
  • 20. A patient interface according to claim 1, wherein the orifice of the foam interfacing portion includes a width of about 15-50 mm.
  • 21. A patient interface according to claim 1, wherein the orifice of the foam interfacing portion includes a height of about 5-30 mm.
  • 22. A patient interface according to claim 1, wherein the foam interfacing portion includes a thickness of about 0.5-50 mm.
  • 23. A patient interface according to claim 1, wherein the foam interfacing portion includes a length of about 10-200 mm and a width of about 10-100 mm.
  • 24. A patient interface according to claim 1, wherein the foam interfacing portion is structured to form a seal with the patient's nares.
  • 25. A patient interface according to claim 1, wherein the exterior surface of the bottom underside portion of the foam interfacing portion substantially surrounds the at least a portion of the positioning and stabilizing structure.
  • 26. A patient interface according to claim 1, wherein the positioning and stabilizing structure is flexible, compressible and/or movable to allow rotational, axial, and/or lateral movement of the foam interfacing portion.
  • 27. A patient interface according to claim 1, wherein at least one of the one or more connectors is disposed on the exterior surface of the bottom underside portion of the foam interfacing portion.
  • 28. A patient interface according to claim 1, wherein the concave shape substantially conforms to a shape of the at least a portion of the positioning and stabilizing structure.
  • 29. A patient interface according to claim 1, wherein the foam is configured and positioned to directly contact under and around the patient's nose in use.
  • 30. A patient interface according to claim 1, wherein the positioning and stabilizing structure includes a frame, and wherein the positioning and stabilizing structure resists the application of tube drag and/or headgear tension to the foam interfacing portion.
  • 31. A patient interface according to claim 1, wherein the foam interfacing portion is wrapped around the positioning and stabilizing structure such that an underside surface of the foam interfacing portion forms an arc shape around the at least a portion of the positioning and stabilizing structure.
  • 32. A patient interface according to claim 1, wherein an entire underside surface of the foam interfacing portion is in contact with the positioning and stabilizing structure.
  • 33. A patient interface according to claim 1, wherein the foam interfacing portion forms an inverted U-shape and the foam interfacing portion covers the at least a portion of the positioning and stabilizing structure.
  • 34. A patient interface according to claim 1, wherein at least one of the one or more connectors is disposed on the exterior surface of the bottom underside portion of the foam interfacing portion, and wherein the concave shape substantially conforms to a shape of the at least a portion of the positioning and stabilizing structure.
  • 35. A patient interface according to claim 1, wherein the foam interfacing portion is wrapped around the positioning and stabilizing structure such that an underside surface of the foam interfacing portion forms an arc shape around the at least a portion of the positioning and stabilizing structure, wherein an entire underside surface of the foam interfacing portion is in contact with the positioning and stabilizing structure,wherein the exterior surface of the bottom underside portion of the foam interfacing portion has a first end at a first side of the foam interfacing portion and a second end at an opposite second side of the foam interfacing portion, the entire exterior surface from the first end to the second end being formed into the concave shape,wherein an exterior surface on a topside patient-contacting portion of the foam interfacing portion has a convex shape that matches a curvature of the concave shape of the exterior surface of the bottom underside portion of the foam interfacing portion,wherein the convex shape of the exterior surface of the topside patient-contacting portion of the foam interfacing portion is configured and positioned to directly contact under the patient's nose in use,wherein a distance between the exterior surface of the bottom underside portion of the foam interfacing portion and the exterior surface of the topside patient-contacting portion of the foam interfacing portion is uniform from the first side of the foam interfacing portion to the second side of the foam interfacing portion,wherein the foam interfacing portion forms an inverted U-shape and the foam interfacing portion covers the at least a portion of the positioning and stabilizing structure,wherein at least one of the one or more connectors is disposed on the exterior surface of the bottom underside portion of the foam interfacing portion, andwherein the concave shape substantially conforms to a shape of the at least a portion of the positioning and stabilizing structure.
Priority Claims (1)
Number Date Country Kind
2008901057 Mar 2008 AU national
CROSS-REFERENCE TO RELATED APPLICATION

This application is a continuation of U.S. patent application Ser. No. 12/735,977, filed Aug. 27, 2010, which was the U.S. national phase of International Application No. PCT/AU2009/000240, filed Feb. 27, 2009, which designated the U.S. and claims the benefit of Australian Provisional Application No. AU 2008901057, filed Mar. 4, 2008, each of which is hereby incorporated herein by reference in its entirety.

US Referenced Citations (380)
Number Name Date Kind
443191 Illing Dec 1890 A
781516 Guthrie, Jr. Jan 1905 A
1081745 Johnston Dec 1913 A
1125542 Humphries Jan 1915 A
1192186 Greene Jul 1916 A
1229050 Donald Jun 1917 A
1282527 Bidonde Oct 1918 A
1362766 McGargill Dec 1920 A
1445010 Feinberg Feb 1923 A
1610793 Kaufman Dec 1926 A
1873160 Sturtevant Aug 1932 A
2353643 Bulbulian Jul 1944 A
2415846 Randall Feb 1947 A
2433565 Korman Dec 1947 A
2625155 Engelder Jan 1953 A
2706983 Matheson et al. Apr 1955 A
2931356 Schwarz Apr 1960 A
3013556 Galleher Dec 1961 A
3670726 Mahon et al. Mar 1972 A
3682171 Dali et al. Aug 1972 A
3739774 Gregory Jun 1973 A
3754552 King Aug 1973 A
3827433 Shannon Aug 1974 A
3861385 Carden Jan 1975 A
3902486 Guichard Sep 1975 A
3905361 Hewson et al. Sep 1975 A
3938614 Ahs Feb 1976 A
3972321 Proctor Aug 1976 A
4006744 Steer Feb 1977 A
4142527 Garcia Mar 1979 A
4153051 Shippert May 1979 A
4156426 Gold May 1979 A
4248218 Fischer Feb 1981 A
4263908 Mizerak Apr 1981 A
4264743 Maruyama et al. Apr 1981 A
4267845 Robertson, Jr. et al. May 1981 A
4273124 Zimmerman Jun 1981 A
4312359 Olson Jan 1982 A
4367735 Dali Jan 1983 A
4367816 Wilkes Jan 1983 A
4406283 Bir Sep 1983 A
4414973 Matheson et al. Nov 1983 A
4422456 Teip Dec 1983 A
4449526 Elam May 1984 A
4455675 Bose et al. Jun 1984 A
4493614 Chu et al. Jan 1985 A
4548200 Wapner Oct 1985 A
4549542 Chein Nov 1985 A
4572323 Randall Feb 1986 A
4587967 Chu et al. May 1986 A
4601465 Roy Jul 1986 A
4617637 Chu et al. Nov 1986 A
4630604 Montesi Dec 1986 A
4641647 Behan Feb 1987 A
4660555 Payton Apr 1987 A
4671271 Bishop et al. Jun 1987 A
4676241 Webb et al. Jun 1987 A
4699139 Marshall et al. Oct 1987 A
4706664 Snook et al. Nov 1987 A
4711636 Bierman Dec 1987 A
4713844 Westgate Dec 1987 A
4753233 Grimes Jun 1988 A
4767411 Edmunds Aug 1988 A
4774946 Ackerman et al. Nov 1988 A
4782832 Trimble et al. Nov 1988 A
4790829 Bowden et al. Dec 1988 A
4802857 Laughlin Feb 1989 A
4803981 Vickery Feb 1989 A
4811730 Milano Mar 1989 A
4830138 Palmaer et al. May 1989 A
4838878 Kalt et al. Jun 1989 A
4899740 Napolitano Feb 1990 A
4907584 McGinnis Mar 1990 A
4915105 Lee Apr 1990 A
4919128 Kopala et al. Apr 1990 A
4919654 Kalt Apr 1990 A
4944310 Sullivan Jul 1990 A
4945907 Tayebi Aug 1990 A
4960121 Nelson et al. Oct 1990 A
4966590 Kalt Oct 1990 A
4969880 Zamierowski Nov 1990 A
4971051 Toffolon Nov 1990 A
4976698 Stokley Dec 1990 A
4989599 Carter Feb 1991 A
4996983 Amrhein Mar 1991 A
5000173 Zalkin et al. Mar 1991 A
5005571 Dietz Apr 1991 A
5020163 Aileo et al. Jun 1991 A
5022900 Bar-Yona et al. Jun 1991 A
5023955 Murphy, II et al. Jun 1991 A
5025805 Nutter Jun 1991 A
5038772 Kolbe et al. Aug 1991 A
5042478 Kopala et al. Aug 1991 A
5046491 Derrick Sep 1991 A
5074297 Venegas Dec 1991 A
5113857 Dickerman et al. May 1992 A
5117818 Palfy Jun 1992 A
5121745 Israel Jun 1992 A
5127397 Kohnke Jul 1992 A
5137017 Salter Aug 1992 A
5138722 Urella et al. Aug 1992 A
D333015 Farmer et al. Feb 1993 S
5188101 Tumolo Feb 1993 A
5207665 Davis et al. May 1993 A
5220699 Farris Jun 1993 A
5243709 Sheehan et al. Sep 1993 A
5243971 Sullivan et al. Sep 1993 A
5245995 Sullivan et al. Sep 1993 A
5261893 Zamierowski Nov 1993 A
5263939 Wortrich Nov 1993 A
5265592 Beaussant Nov 1993 A
5265595 Rudolph Nov 1993 A
5267557 Her-Mou Dec 1993 A
5269296 Landis Dec 1993 A
5271391 Graves Dec 1993 A
5304146 Johnson et al. Apr 1994 A
5299599 Farmer et al. May 1994 A
5335656 Bowe et al. Aug 1994 A
5349949 Schegerin Sep 1994 A
5355878 Griffiths et al. Oct 1994 A
5355893 Mick et al. Oct 1994 A
5364367 Banks et al. Nov 1994 A
5372130 Stem et al. Dec 1994 A
5372388 Gargiulo Dec 1994 A
5372389 Tam et al. Dec 1994 A
5372390 Conway et al. Dec 1994 A
5372391 Bast et al. Dec 1994 A
5375593 Press Dec 1994 A
5385141 Granatiero Jan 1995 A
5394568 Brostrom et al. Mar 1995 A
5396885 Nelson Mar 1995 A
5398676 Press et al. Mar 1995 A
5400776 Bartholomew Mar 1995 A
5419318 Tayebi May 1995 A
5425359 Liou Jun 1995 A
5429683 Le Mitouard Jul 1995 A
5437267 Weinstein et al. Aug 1995 A
5441046 Starr et al. Aug 1995 A
5462528 Roewer Oct 1995 A
5477852 Landis et al. Dec 1995 A
5488948 Dubruille et al. Feb 1996 A
5509409 Weatherholt Apr 1996 A
5513634 Jackson May 1996 A
5513635 Bedi May 1996 A
5526806 Sansoni Jun 1996 A
5533506 Wood Jul 1996 A
5538000 Rudolph Jul 1996 A
5538001 Bridges Jul 1996 A
5540223 Starr et al. Jul 1996 A
5560354 Berthon-Jones et al. Oct 1996 A
5570684 Behr Nov 1996 A
5592938 Scarberry et al. Jan 1997 A
5623923 Bertheau et al. Apr 1997 A
5647357 Barnett et al. Jul 1997 A
5653228 Byrd Aug 1997 A
5655527 Scarberry et al. Aug 1997 A
5662101 Ogden et al. Sep 1997 A
5682881 Winthrop et al. Nov 1997 A
D293613 Wingler Jan 1998 S
5704345 Berthon-Jones et al. Jan 1998 A
5707342 Tanaka Jan 1998 A
5724965 Handke et al. Mar 1998 A
5735272 Dillon et al. Apr 1998 A
5740799 Nielson Apr 1998 A
5752511 Simmons et al. May 1998 A
5794619 Edeiman et al. Aug 1998 A
5807341 Heim Sep 1998 A
5842469 Rapp et al. Dec 1998 A
5906203 Klockseth et al. May 1999 A
5918598 Belfer et al. Jul 1999 A
5921239 McCall Jul 1999 A
5954049 Foley et al. Sep 1999 A
5975079 Hellings et al. Nov 1999 A
6012455 Goldstein Jan 2000 A
6019101 Cotner et al. Jan 2000 A
6026811 Settle Feb 2000 A
6044844 Kwok et al. Apr 2000 A
6082360 Rudolph et al. Jul 2000 A
6086118 McNaughton et al. Jul 2000 A
6095996 Steer et al. Aug 2000 A
6098205 Schwartz et al. Aug 2000 A
6109263 Feuchtgruber Aug 2000 A
6112746 Kwok et al. Sep 2000 A
6119693 Kwok et al. Sep 2000 A
6119694 Correa Sep 2000 A
6123071 Berthon-Jones et al. Sep 2000 A
6123082 Berthon-Jones Sep 2000 A
6139787 Harrison Oct 2000 A
6152137 Schwartz et al. Nov 2000 A
6193914 Harrison Feb 2001 B1
6196223 Belfer et al. Mar 2001 B1
6211263 Cinelli et al. Apr 2001 B1
6231548 Bassett May 2001 B1
6241930 Harrison Jun 2001 B1
6258066 Urich Jul 2001 B1
6295366 Haller et al. Sep 2001 B1
6328038 Kessler et al. Dec 2001 B1
6338340 Finch et al. Jan 2002 B1
6341606 Bordewick et al. Jan 2002 B1
6347631 Hansen et al. Feb 2002 B1
6357441 Kwok et al. Mar 2002 B1
6358279 Tahi et al. Mar 2002 B1
6374826 Gunaratnam et al. Apr 2002 B1
6412487 Gunaratnam Jul 2002 B1
6412488 Barnett et al. Jul 2002 B1
6412593 Jones Jul 2002 B1
6412847 De Gaillard Jul 2002 B2
6419660 Russo Jul 2002 B1
6422238 Lithgow Jul 2002 B1
6423036 Van Huizen Jul 2002 B1
6431172 Bordewick Aug 2002 B1
6434796 Speirs Aug 2002 B1
6439234 Curti et al. Aug 2002 B1
6448303 Paul Sep 2002 B1
6467482 Boussignac Oct 2002 B1
6467483 Kopacko Oct 2002 B1
6470887 Martinez Oct 2002 B1
6478026 Wood Nov 2002 B1
6482178 Andrews et al. Nov 2002 B1
6491034 Gunaratnam et al. Dec 2002 B1
6513526 Kwok et al. Feb 2003 B2
6530373 Patron et al. Mar 2003 B1
6532961 Kwok et al. Mar 2003 B1
6536435 Fecteau et al. Mar 2003 B1
6561188 Ellis May 2003 B1
6561190 Kwok et al. May 2003 B1
6561192 Palmer May 2003 B2
6561193 Noble May 2003 B1
6571798 Thornton Jun 2003 B1
6579267 Lynch et al. Jun 2003 B2
6581601 Ziaee Jun 2003 B2
6581602 Kwok et al. Jun 2003 B2
6584975 Taylor Jul 2003 B1
6595214 Hecker et al. Jul 2003 B1
6595215 Wood Jul 2003 B2
6607516 Cinelli et al. Aug 2003 B2
6627289 Dilnik et al. Sep 2003 B1
6631718 Lovell Oct 2003 B1
6634358 Kwok et al. Oct 2003 B2
6637434 Noble Oct 2003 B2
6644315 Ziaee Nov 2003 B2
6655385 Curti et al. Dec 2003 B1
6663600 Bierman et al. Dec 2003 B2
6669712 Cardoso Dec 2003 B1
D485905 Moore et al. Jan 2004 S
6679257 Robertson et al. Jan 2004 B1
6679265 Strickland et al. Jan 2004 B2
6701927 Kwok et al. Mar 2004 B2
6710099 Cinelli et al. Mar 2004 B2
6766800 Chu et al. Jul 2004 B2
6766817 da Silva Jul 2004 B2
6776162 Wood Aug 2004 B2
6776163 Dougill et al. Aug 2004 B2
6789543 Cannon Sep 2004 B2
6805117 Ho et al. Oct 2004 B1
6807967 Wood Oct 2004 B2
6817362 Gelinas Nov 2004 B2
6820617 Robertson et al. Nov 2004 B2
6823865 Drew et al. Nov 2004 B2
6823869 Raje et al. Nov 2004 B2
6826783 Grove et al. Dec 2004 B1
6834650 Fini Dec 2004 B1
6860270 Sniadach Mar 2005 B2
6895965 Scarberry et al. May 2005 B2
6907882 Ging et al. Jun 2005 B2
6918404 Dias da Silva Jul 2005 B2
6926004 Schumacher Aug 2005 B2
6938620 Payne, Jr. Sep 2005 B2
6968844 Liland Nov 2005 B2
6972003 Bierman et al. Dec 2005 B2
6986352 Frater et al. Jan 2006 B2
6997177 Wood Feb 2006 B2
7011090 Drew et al. Mar 2006 B2
7018362 Bierman et al. Mar 2006 B2
7052127 Harrison May 2006 B2
7066586 da Silva Jun 2006 B2
7076282 Munro et al. Jul 2006 B2
7080645 Genger et al. Jul 2006 B2
7101359 Kline et al. Sep 2006 B2
7107989 Frater et al. Sep 2006 B2
7146976 McKown Dec 2006 B2
7152599 Thomas Dec 2006 B2
7152601 Barakat et al. Dec 2006 B2
7178525 Matula et al. Feb 2007 B2
7191781 Wood Mar 2007 B2
7207328 Altemus Apr 2007 B1
7210481 Lovell et al. May 2007 B1
7237551 Ho et al. Jul 2007 B2
7243723 Surjaatmadja Jul 2007 B2
D550836 Chandran et al. Sep 2007 S
D552733 Criscuolo et al. Oct 2007 S
7285255 Kadlec et al. Oct 2007 B2
7302950 Berthon-Jones et al. Dec 2007 B2
7318437 Gunaratnam et al. Jan 2008 B2
7331348 Beevers Feb 2008 B1
7523754 Lithgow Apr 2009 B2
7658189 Davidson Feb 2010 B2
20010020474 Hecker et al. Sep 2001 A1
20020005198 Kwok et al. Jan 2002 A1
20020029780 Frater et al. Mar 2002 A1
20020046755 DeVoss Apr 2002 A1
20020053347 Ziaee May 2002 A1
20020066452 Kessler et al. Jun 2002 A1
20020069872 Gradon et al. Jun 2002 A1
20020096178 Ziaee Jul 2002 A1
20020124849 Billette De Villemeur Sep 2002 A1
20020143296 Russo Oct 2002 A1
20020157673 Kessler et al. Oct 2002 A1
20020174868 Kwok et al. Nov 2002 A1
20020185134 Bishop Dec 2002 A1
20030000526 Goebel Jan 2003 A1
20030019495 Palkon et al. Jan 2003 A1
20030019496 Kopacko et al. Jan 2003 A1
20030079749 Strickland et al. May 2003 A1
20030089373 Gradon et al. May 2003 A1
20030111080 Olsen et al. Jun 2003 A1
20030154980 Berthon-Jones et al. Aug 2003 A1
20030168063 Gambone et al. Sep 2003 A1
20030196656 Moore et al. Oct 2003 A1
20030196658 Ging et al. Oct 2003 A1
20040025882 Madaus et al. Feb 2004 A1
20040025885 Payne, Jr. Feb 2004 A1
20040045551 Eaton et al. Mar 2004 A1
20040065328 Amarasinghe et al. Apr 2004 A1
20040106891 Langan et al. Jun 2004 A1
20040107968 Griffiths Jun 2004 A1
20040111104 Schein et al. Jun 2004 A1
20040112384 Lithgow et al. Jun 2004 A1
20040118406 Lithgow et al. Jun 2004 A1
20040127856 Johnson Jul 2004 A1
20040211428 Jones Oct 2004 A1
20040226564 Persson Nov 2004 A1
20040226566 Gunaratnam et al. Nov 2004 A1
20050011523 Aylsworth et al. Jan 2005 A1
20050028822 Sleeper et al. Feb 2005 A1
20050033247 Thompson Feb 2005 A1
20050039757 Wood Feb 2005 A1
20050051171 Booth Mar 2005 A1
20050051176 Riggins Mar 2005 A1
20050056286 Huddart et al. Mar 2005 A1
20050061326 Payne, Jr. Mar 2005 A1
20050066976 Wondka Mar 2005 A1
20050101933 Marrs et al. May 2005 A1
20050150495 Rittner et al. Jul 2005 A1
20050155604 Ging et al. Jul 2005 A1
20050211252 Lang et al. Sep 2005 A1
20050241644 Lynch et al. Nov 2005 A1
20050284481 Meyer Dec 2005 A1
20060060200 Ho et al. Mar 2006 A1
20060081250 Bordewick et al. Apr 2006 A1
20060095008 Lampropoulos et al. May 2006 A1
20060095009 Lampropoulos et al. May 2006 A1
20060118117 Berthon-Jones Jun 2006 A1
20060124131 Chandran et al. Jun 2006 A1
20060137690 Gunaratnam et al. Jun 2006 A1
20060174887 Chandran et al. Aug 2006 A1
20060020514 Jones et al. Sep 2006 A1
20060201514 Jones Sep 2006 A1
20060207597 Wright Sep 2006 A1
20060237017 Davidson et al. Oct 2006 A1
20060283461 Lubke et al. Dec 2006 A1
20070023044 Kwok et al. Feb 2007 A1
20070125387 Zollinger et al. Jun 2007 A1
20070144525 Davidson et al. Jun 2007 A1
20070186930 Davidson et al. Aug 2007 A1
20070267017 McAuley et al. Nov 2007 A1
20070272249 Chandran et al. Nov 2007 A1
20070282272 Bannon et al. Dec 2007 A1
20080004573 Kaufmann et al. Jan 2008 A1
20080006277 Worboys et al. Jan 2008 A1
20080047560 Veliss et al. Feb 2008 A1
20080060649 Veliss et al. Mar 2008 A1
20080065022 Kyvik et al. Mar 2008 A1
20080110469 Weinberg May 2008 A1
20080200880 Kyvik et al. Aug 2008 A1
20080257354 Davidson et al. Oct 2008 A1
20090044808 Guney et al. Feb 2009 A1
20100000534 Kooij et al. Jan 2010 A1
20100018534 Veliss et al. Jan 2010 A1
20110000492 Veliss et al. Jan 2011 A1
Foreign Referenced Citations (91)
Number Date Country
199651130 Oct 1996 AU
2005100738 Nov 2005 AU
185017 May 1907 DE
30 11 900 Oct 1980 DE
146 688 Feb 1981 DE
37 19 009 Dec 1988 DE
39 27 038 Feb 1991 DE
297 23 101 Jul 1998 DE
197 03 526 Aug 1998 DE
199 44 242 Mar 2001 DE
10002571 Jul 2001 DE
102 13 905 Oct 2002 DE
10 2004 055 433 Nov 2004 DE
0 288 937 Nov 1988 EP
0 427 474 May 1991 EP
0 466 960 Jan 1992 EP
0 303 090 Apr 1992 EP
0 658 356 Jun 1995 EP
0 776 679 Jun 1997 EP
1 099 452 May 2001 EP
1 258 266 Nov 2002 EP
1 293 227 Mar 2003 EP
1 481 702 Dec 2004 EP
2 720 280 Dec 1995 FR
532214 Jan 1941 GB
2 176 404 Dec 1986 GB
2 368 533 May 2002 GB
2 385 533 Aug 2003 GB
2000-515784 Nov 2000 JP
WO 1982003548 Oct 1982 WO
WO 1987001950 Apr 1987 WO
WO 1992020392 Nov 1992 WO
WO 1992020395 Nov 1992 WO
WO 1996028207 Sep 1996 WO
WO 1998004310 Feb 1998 WO
WO 1998012965 Apr 1998 WO
WO 1998023305 Jun 1998 WO
WO 1999016327 Apr 1999 WO
WO 1999025410 May 1999 WO
WO 1999043375 Sep 1999 WO
WO 1999061088 Dec 1999 WO
WO 2000020072 Apr 2000 WO
WO 2000038772 Jul 2000 WO
WO 2000050121 Aug 2000 WO
WO 0069521 Nov 2000 WO
WO 2000072905 Dec 2000 WO
WO 2000074758 Dec 2000 WO
WO 2000076568 Dec 2000 WO
WO 2000078384 Dec 2000 WO
WO 2001062326 Aug 2001 WO
WO 2001095965 Dec 2001 WO
WO 2001097892 Dec 2001 WO
WO 2001097893 Dec 2001 WO
WO 2002038221 May 2002 WO
WO 2002045784 Jun 2002 WO
WO 2003090827 Nov 2003 WO
WO 2003105921 Dec 2003 WO
WO 2004022146 Mar 2004 WO
WO 2004041342 May 2004 WO
WO 2004078230 Sep 2004 WO
WO 2005053781 Jun 2005 WO
WO 2005063328 Jul 2005 WO
WO 2005086943 Sep 2005 WO
WO 2005099801 Oct 2005 WO
WO 2005110220 Nov 2005 WO
WO 2005118040 Dec 2005 WO
PCTAU2006000031 Jan 2006 WO
PCTAU2006000417 Mar 2006 WO
PCTAU2006000770 Jun 2006 WO
WO 2006069415 Jul 2006 WO
WO 2006074513 Jul 2006 WO
WO 2006074516 Jul 2006 WO
WO 2006099658 Sep 2006 WO
WO 2006130903 Dec 2006 WO
WO 2007009182 Jan 2007 WO
WO 2007016424 Feb 2007 WO
WO 2007041751 Apr 2007 WO
WO 2007041786 Apr 2007 WO
WO 2007048174 May 2007 WO
WO 2007053878 May 2007 WO
PCTAU2007001936 Dec 2007 WO
WO 2007143772 Dec 2007 WO
WO 2007145534 Dec 2007 WO
WO 2008070929 Dec 2007 WO
WO 2008011682 Jan 2008 WO
WO 2008011683 Jan 2008 WO
WO 2008040050 Apr 2008 WO
WO 2004073778 Jun 2008 WO
WO 2009108994 Sep 2009 WO
WO 2009109004 Sep 2009 WO
WO 2010028425 Mar 2010 WO
Non-Patent Literature Citations (93)
Entry
U.S. Appl. No. 10/385,701, filed Aug. 2003, Berthon-Jones et al.
U.S. Appl. No. 10/533,928, filed Jul. 2005, Berthon-Jones.
U.S. Appl. No. 10/584,711, filed Dec. 2004, Davidson.
U.S. Appl. No. 10/655,622, filed Sep. 2003, Lithgow.
U.S. Appl. No. 10/781,929, filed Jan. 2008, Gunaratnam et al.
U.S. Appl. No. 10/871,929, filed Feb. 2004, Surjaatmadja.
U.S. Appl. No. 11/080,446, filed Jul. 2005, Ging et al.
U.S. Appl. No. 11/447,295, filed Jun. 2006, Lubke et al.
U.S. Appl. No. 11/474,415, filed Jun. 2006, Davidson et al.
U.S. Appl. No. 11/491,016, filed Feb. 2007, Kwok et al.
U.S. Appl. No. 11/703,082, filed Feb. 2007, Davidson.
U.S. Appl. No. 11/878,932, filed Jul. 2007, Veliss et al.
U.S. Appl. No. 11/878,933, filed Jul. 2007, Veliss et al.
U.S. Appl. No. 12/081,696, filed Apr. 2008, Davidson et al.
U.S. Appl. No. 12/085,191, filed May 2008, Kwok et al.
U.S. Appl. No. 12/219,852, filed Jan. 2008 ,Guney et al.
U.S. Appl. No. 12/309,696, filed Jan. 2009, Kwok et al.
U.S. Appl. No. 12/382,517, filed Mar. 2009, Lithgow.
U.S. Appl. No. 12/448,250, filed Jun. 2009, Veliss et al.
U.S. Appl. No. 12/461,448, filed Aug. 2009, Berthon-Jones.
U.S. Appl. No. 12/478,537, filed Jun. 2009, Kooij et al.
U.S. Appl. No. 12/656,466, filed Jan. 2010, Biener et al.
U.S. Appl. No. 12/700,878, filed Feb. 2010, Davidson et al.
U.S. Appl. No. 60/424,686, filed Nov. 2002, Lithgow.
U.S. Appl. No. 60/483,622, filed Jul. 2003, Kwok et al.
U.S. Appl. No. 60/533,214, filed Dec. 2003, Drew.
U.S. Appl. No. 60/634,802, filed Dec. 2004, Chandran.
U.S. Appl. No. 60/645,672, filed Jan. 2005, Chandran.
U.S. Appl. No. 60/795,615, filed Apr. 2006, Judson et al.
U.S. Appl. No. 60/833,841, filed Jul. 2006, Veliss.
U.S. Appl. No. 60/835,442, filed Aug. 2006, Selvarajan et al.
U.S. Appl. No. 60/852,649, filed Oct. 2006, Selvarajan et al.
U.S. Appl. No. 60/874,968, filed Dec. 2006, Kwok et al.
U.S. Appl. No. 60/907,856, filed Apr. 2007, Davidson et al.
U.S. Appl. No. 60/924,241, filed May 2007, Kwok et al.
U.S. Appl. No. 60/929,393, filed Jun. 2007, Kwok et al.
U.S. Appl. No. 60/935,179, filed Jul. 2007, Guney et al.
U.S. Appl. No. 60/935,336, filed Aug. 2007, Davidson et al.
U.S. Appl. No. 60/996,160, filed Nov. 2007, Guney et al.
U.S. Appl. No. 61/006,409, filed Jan. 2008, Guney et al.
U.S. Appl. No. 61/031,407, filed Feb. 2008, Henry et al.
U.S. Appl. No. 61/064,818, filed Mar. 2008, Guney et al.
U.S. Appl. No. 61/071,512, filed May 2008, Guney et al.
U.S. Appl. No. 61/213,326, filed May 2009, Dravitzki et al.
U.S. Appl. No. 61/222,711, filed Jul. 2009, Dravitzki et al.
U.S. Appl. No. 61/263,175, filed Nov. 2009, Dravitzki et al.
U.S. Appl. No. 61/272,162, filed Aug. 2009, Dravitzki et al.
U.S. Appl. No. 61/272,250, filed Sep. 2009, Dravitzki et al.
International Preliminary Report on Patentability issued in PCT/AU2009/000240 (dated Sep. 7, 2010).
Supplementary European Search Report dated Dec. 18, 2009 in European Application No. 03810331.3.
International Search Report issued in Appln. No. PCT/AU2009/000240 (dated May 21, 2009).
“Ear Loop Face Mask”.
Adam J. Singer MD et al. “The Cyanoacrylate Topical Skin Adhesives,” American Journal of Emergency Medicine, vol. 26, 2008, pp. 490-496.
Webster's Third New International Dictionary, 1993, Dictionary definition for adjustable, bendable, and mild steel.
ComfortLite™, Respironics, http://comfortlite.respironics.com.
ComfortLite™ 2, Respironics, http://comfortlite2.respironics.com.
“If You Hate CPAP! You Need CPAP Pro®,” www.cpappro.com.
Webster's New World Dictionary, Third College Edition 1988, definition for engaged and flexible.
EP Supplementary Search Report issued in EP Application 03793493, dated Dec. 2, 2009.
European Search Report filed on Jul. 27, 2009 in EP Application No. 07784697.0.
European Search Report issued in EP 07845378.4, dated Dec. 1, 2009.
Examination Report filed in New Zealand Application 539836, dated Aug. 25, 2005.
Examiner's Report No. 3 dated Nov. 18, 2009 in New Zealand Application No. 2003275762.
Extended European Search Report dated Mar. 19, 2009 in European Application No. EP 08161249.
Extended European Search Report dated Sep. 3, 2009 in corresponding EP Application No. 09161984.1.
Extended European Search Report. Application No. EP 08154854, dated Nov. 27, 2008.
Fisher and Paykel Col.—Product Family—http://www.fphcare.com/osa/products.asp/.
Hans Rudolph, Inc.—Mask Products—http://www.rudolphkc.com/products.php?category=MASKS.
International Preliminary Report on Patentability for PCT/AU2004/001832, dated Jul. 3, 2006.
International Search Report filed in PCT/AU2005/000803, dated Jun. 30, 2005.
International Search Report filed in PCT/AU2006/000770, dated Aug. 3, 2006.
International Search Report for PCT/AU2007/001052, dated Oct. 9, 2007.
International Search Report for PCT/AU2007/001051, dated Nov. 5, 2007.
International Search Report for PCT/AU2004/001832, dated Mar. 24, 2005.
International Search Report for PCT/AU2007/001936, dated Mar. 4, 2008.
Joel W. Beam, “Tissue Adhesives for Simple Traumatic Lacerations,” Journal of Athletic Training, 2008, vol. 43, No. 2, pp. 222-224.
Merriam-Webster Online Dictionary definition of moveable from the 14th century.
Office Action dated Dec. 22, 2009 in European Appln. No. 04802133.1.
Office Action issued in Japanese Application No. 2007-513621 (dated Aug. 24, 2010) with English translation.
ResMed Co.—Mask Products—http://resmed.com/portal/site/ResMedUS/index.jsp?.
Respironics Co.—Mask Family—http://masksfamily.respironics.com/.
Snapp Nasal Interface, Tiara Medical Systems, Inc.—http://www.tiaramed.com/asp_shops/shopdisplayproducts.asp?id=109&cat=SNAPP%2A+Nasal+Interface.
Subbu Venkatraman et al., “Review Skin Adhesives and Skin Adhesion 1. Transdermal Drug Delivery Systems,” Biomaterials, vol. 19, 1998, pp. 1119-1136.
Supplementary European Search Report dated Sep. 8, 2009 in European Appln. No. 04802133.1.
Unsolicited email from Elson Silva, PhD, dated Mar. 28, 2008, “Requesting IDS of U.S. Pat. No. 6,766,817 for patents on fluids moving on porosity by Unsaturated Hydraulic Flow,” (email provided in both HTML and plain text format).
International Search Report PCT/AU2003/001163, dated Nov. 4, 2003.
International Search Report PCT/AU2003/001471, dated Feb. 12, 2004.
International Search Report PCT/AU2009/000240, dated May 21, 2009.
International Search Report PCT/AU2009/000262, dated Jun. 9, 2009.
International Search Report PCT/AU2009/001144, dated Dec. 18, 2009.
Office Action issued in European Appln. No. 05746824.1 (dated Mar. 22, 2011).
A Communication pursuant to Article 94(3) EPC dated Apr. 4, 2017, in a corresponding EP Application No. 09 716 773.8 (9 pages).
A Communication Pursuant to Article 94(3) EPC dated Jun. 4, 2018, in a corresponding European Patent Application No. EP 09 716 773.8 (10 pages).
Related Publications (1)
Number Date Country
20180304037 A1 Oct 2018 US
Continuations (1)
Number Date Country
Parent 12735977 US
Child 16022180 US